• Record quarterly sales revenue of $5.94m, exceeding forecast by 8%
• Sales revenue increased 40% vs prior corresponding period
• Sales revenue increased 19% quarter-on-quarter

Biome Australia Limited (ASX: BIO), a microbiome health company, has reported record quarterly sales revenue of $5.94 million for Q1 FY26. This result exceeded the company's forecast target of $5.5 million by $440,000 or 8%. The Q1 sales revenue represents a 40% increase compared to the prior corresponding period (Q1 FY25) and a 19% increase quarter-on-quarter (Q4 FY25). The company's strong growth trajectory places it on track to achieve its Vision 27 three-year revenue guidance of at least $75 million. Biome's Activated Probiotics brand has delivered more than 50% sell-through growth in pharmacy over the past 12 months, compared to expected category growth of only ~6%, representing more than eight times outperformance. This exceptional sell-through growth from the existing customer base demonstrates the strength of Biome's market position and product demand.

Biome's Q1 sales revenue represents an annualised run rate of $23.7 million, with growth expected to continue through the remainder of FY26.

Biome remains on track to achieve its Vision 27 three-year revenue guidance of at least $75 million, demonstrating continued momentum toward the company's strategic targets.